Table 1 Study cohort (n = 416) characteristics of the according classification criteria.
CD4+ T-cells ≤200 cells/µL | CD4+ T-cells >200 cells/µL | P- value | ||
|---|---|---|---|---|
INR (n = 95) | IR (n = 106) | Control (n = 215) | ||
Pre-ART clinical characteristics | ||||
Age at cART initiation (years) | 42 [37–51] | 37 [33–42] | 37 [31–45] | <0.001 |
Male | 58 (79) | 70 (82) | 155 (83) | 0.807 |
Risk factor | 0.060 | |||
Heterosexual | 29 (40) | 31 (36) | 62 (33) | |
Homo/Bisexual | 26 (36) | 47 (55) | 101 (54) | |
Intravenous drug abuse | 15 (20) | 6 (7) | 19 (10) | |
Other/Unknown | 3 (4) | 2 (2) | 5 (3) | |
CD4+ T-cell count (cells/µL) | 51 [17–111] | 129 [51–181] | 333 [272–441] | <0.001 |
Plasma HIV RNA load (log copies/mL) | 5.30 [4.82–5.62] | 5.06 [4.71–5.61] | 4.87 [4.33–5.25] | <0.001 |
AIDS indicator condition | 30 (41) | 21 (24) | 13 (7) | <0.001 |
HCV co-infection (Positive) | 13 (20) | 10 (12) | 27 (15) | 0.410 |
ART clinical characteristics | ||||
48 weeks CD4+ T-cell count (cells/µL) | 167 [110–216] | 350 [294–422] | 532 [408–699] | <0.001 |
ΔCD4+ T-cell count | 95 [47–142] | 239 [187–316] | 170 [64–289] | <0.001 |
Pre-ART plasma IL-7/IL-7R (n = 345) | (n = 73) | (n = 86) | (n = 187) | |
Log IL-7 (pg/mL) | 2.65 [2.53–2.82] | 2.67 [2.54–2.81] | 2.72 [2.60–2.99] | 0.037 |
Log IL-7R (ng/mL) | 2.34 [2.02–2.49] | 2.33 [2.08–2.54] | 2.34 [2.16–2.63] | 0.264 |